Skip to main content
. 2006 Dec 4;56(6):782–789. doi: 10.1136/gut.2006.109868

Table 2 Plasma median osteopontin levels in patients with gastric cancer with different clinicopathological features.

Plasma OPN level (ng/ml) Median (mean±SE) p Value*
Helicobacter pylori
 Seronegative (n = 51) 78.6 (94.2±10.9)
 Seropositive (n = 81) 78.0 (86.2±7.2) NS
Stage
 I (n = 42) 59.3 (66.1±8.2)
 II (n = 23) 63.7 (74.5±8.2) NS†
 III (n = 40) 89.9 (96.9±10.6) 0.003†
 IV (n = 27) 97.0 (126.9±18.8) <0.001†
Serosal invasion
Absent (n = 52) 66.3 (73.6±7.4)
 Present (n = 80) 84.2 (99.5±8.7) 0.017
Lymph node metastasis
 Absent (n = 49) 63.3 (68.9±7.1)
 Present (n = 83) 90.2 (101.6±8.5) 0.003‡
 pN1 (n = 56) 82.9 (94.7±9.4) 0.018‡
 pN2, N3 (n = 27) 92.4 (115.8±17.3) 0.003‡
Lymphatic invasion
 Absent (n = 76) 64.5 (76.0±6.9)
 Present (n = 56) 91.8 (107.5±10.5) 0.003
Venous invasion
 Absent (n = 77) 63.7 (82.8±8.3)
 Present (n = 55) 84.1 (98.5±8.9) 0.035
Liver metastasis
 Absent (n = 124) 75.6 (82.2±5.3)
 Present (n = 8) 166.5 (200.2±45.3) 0.002

*p Value calculated by non‐parametric Mann Whitney U test.

†Compared with stage I.

‡Compared with no lymph node metastasis.

NS, non‐significant; SE, standard error.